TOMEI, L. Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study. Rivista di Immunologia e Allergologia Pediatrica, [S. l.], v. 36, n. 4, p. 40–41, 2023. Disponível em: https://www.riaponline.it/article/view/106. Acesso em: 31 jan. 2023.